Abstract
Chronic obstructive pulmonary disease (COPD) is characterized by reduced sensitivity of cells to the anti-inflammatory effects of glucocorticoids (GCs). Azithromycin and a low dose theophylline have a significant impact on molecular mechanisms leading to corticosteroid resistance. The aim of this study was to evaluate the ability of azithromycin and theophylline to enhance the anti-inflammatory effects of GCs on the production of cytokines by NK and NKT-like blood cells of COPD patients. Whole blood cells from COPD patients (n = 21) were incubated in the presence of budesonide (10 nM), azithromycin (10 μg/mL), theophylline (1 μM), or their combinations and stimulated with phorbol myristate acetate (50 ng/mL). Intracellular production of proinflammatory cytokines in NK (CD3-CD56+) and NKT-like (CD3+CD56+) blood cells was analyzed by flow cytometry. Budesonide reduced synthesis of interleukin 4 (IL-4), CXCL8, tumor necrosis factor α (TNFα) by NK and NKT-like cells, as well as production of interferon γ (IFNγ) by NK cells. Azithromycin suppressed production of IL-4 and CXCL8 by NK and NKT-like cells, and theo-phylline inhibited IL-4 synthesis by these lymphocytes. The combination of azithromycin and budesonide had a more pronounced inhibitory effect on the production of IL-4 and CXCL8 by NK and NKT-like cells than the effect of these drugs alone. The combination of theophylline and budesonide suppressed synthesis of IL-4 and CXCL8 by NK and NKT-like cells, as well as the production of TNFα and IFNγ by NK cells stronger than budesonide alone. The obtained results demonstrate the benefits for the combined use of GCs with theophylline at a low dose or azithromycin to suppress the inflammatory process in patients with COPD.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS1990750821040053/MediaObjects/11828_2021_5128_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS1990750821040053/MediaObjects/11828_2021_5128_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS1990750821040053/MediaObjects/11828_2021_5128_Fig3_HTML.gif)
Similar content being viewed by others
REFERENCES
Vogelmeier, C.F., Criner, G.J., Martinez, F.J., Anzueto, A., Barnes, P.J., Bourbeau, J., Celli, B.R., Chen, R., Decramer, M., Fabbri, L.M., Frith, P., Halpin, D.M., López Varela, M.V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D.D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J.A., and Agustí, A., Am. J. Respir. Crit. Care Med., 2017, vol. 195, no. 5, pp. 557−582. https://doi.org/10.1164/rccm.201701-0218PP
Barnes, P.J., Nat. Rev. Immunol., 2018, vol. 18, no. 7, pp. 454–466. https://doi.org/10.1038/s41577-018-0006-6
Yang, I.A., Clarke, M.S., Sim, E.H., and Fong, K.M., Cochrane Database Syst. Rev., 2012, vol. 7, CD002991. https://doi.org/10.1002/14651858.CD002991.pub3
Kadushkin, A.G. and Taganovich, A.D., Pulmonologiya, 2016, vol. 26, no. 6, pp. 736–747. https://doi.org/10.18093/0869-0189-2016-26-6-736-747
Hodge, G. and Hodge, S., Int. J. Mol. Sci., 2019, vol. 20, no. 6, 1511. https://doi.org/10.3390/ijms20061511
Freeman, C.M., Stolberg, V.R., Crudgington, S., Martinez, F.J., Han, M.K., Chensue, S.W., Arenberg, D.A., Meldrum, C.A., McCloskey, L., and Curtis, J.L., PLoS One, 2014, vol. 9, no. 7, e103840. https://doi.org/10.1371/journal.pone.0103840
Reijnders, T.D.Y., Saris, A., Schultz, M., and van der Poll, T., Lancet Respir. Med., 2020, vol. 8, no. 6, pp. 619–630. https://doi.org/10.1016/S2213-2600(20)30080-1
Sun, X.J., Li, Z.H., Zhang, Y., Zhou, G., Zhang, J.Q., Deng, J.M., Bai, J., Liu, G.N., Li, M.H., MacNee, W., Zhong, X.N., and He, Z.Y., Am. J. Physiol. Lung Cell Mol. Physiol., 2015, vol. 309, no. 2, pp. L139–L146. https://doi.org/10.1152/ajplung.00292.2014
Kobayashi, Y., Wada, H., Rossios, C., Takagi, D., Charron, C., Barnes, P.J., and Ito, K., Br. J. Pharmacol., 2013, vol. 169, no. 5, pp. 1024–1034. https://doi.org/10.1111/bph.12187
Ceccato, A., Cilloniz, C., Ranzani, O.T., Menendez, R., Agusti, C., Gabarrus, A., Ferrer, M., Sibila, O., Niederman, M.S., and Torres, A., PLoS One, 2017, vol. 12, no. 6, e0178022. https://doi.org/10.1371/journal.pone.0178022
Barnes, P.J., Am. J. Respir. Crit. Care Med., 2013, vol. 188, no. 8, pp. 901–906. https://doi.org/10.1164/rccm.201302-0388PP
Devereux, G., Cotton, S., Fielding, S., McMeekin, N., Barnes, P.J., Briggs, A., Burns, G., Chaudhuri, R., Chrystyn, H., Davies, L., De Soyza, A., Gompertz, S., Haughney, J., Innes, K., Kaniewska, J., Lee, A., Morice, A., Norrie, J., Sullivan, A., Wilson, A., and Price, D., JAMA, 2018, vol. 320, no. 15, pp. 1548−1559. https://doi.org/10.1001/jama.2018.14432
To, Y., Ito, K., Kizawa, Y., Failla, M., Ito, M., Kusama, T., Elliott, W.M., Hogg, J.C., Adcock, I.M., and Barnes, P.J., Am. J. Respir. Crit. Care Med., 2010, vol. 182, no. 7, pp. 897−904. https://doi.org/10.1164/rccm.200906-0937OC
Krijgsman, D., Hokland, M., and Kuppen, P.J.K., Front. Immunol., 2018, vol. 9, 367. https://doi.org/10.3389/fimmu.2018.00367
Abel, A.M., Yang, C., Thakar, M.S., and Malarkannan, S., Front. Immunol., 2018, vol. 9, 1869. https://doi.org/10.3389/fimmu.2018.01869
Luzina, I.G., Lockatell, V., Todd, N.W., Highsmith, K., Keegan, A.D., Hasday, J.D., and Atamas, S.P., J. Leukoc. Biol., 2011, vol. 89, no. 5, pp. 763–770. https://doi.org/10.1189/jlb.0510271
Zhu, Y., Song, D., Song, Y., and Wang, X., J. Transl. Med., 2019, vol. 17, no. 1, 147. https://doi.org/10.1186/s12967-019-1894-3
Lin, S.J., Yan, D.C., Lee, W.I., Kuo, M.L., Hsiao, H.S., and Lee, P.Y., Int. Immunopharmacol., 2012, vol. 13, no. 1, pp. 8–14. https://doi.org/10.1016/j.intimp.2012.02.013
Webster, J.M., Kempen, L.J.A.P, Hardy, R.S., and Langen, R.C.J., Front. Physiol., 2020, vol. 11, 597675. https://doi.org/10.3389/fphys.2020.597675
Barnes, P.J., J. Allergy Clin. Immunol., 2016, vol. 138, no. 1, pp. 16–27. https://doi.org/10.1016/j.jaci.2016.05.011
Kadushkin, A.G., Taganovich, A.D., and Tagano-vich, N.D., Pulmonologiya, 2013, no. 5, pp. 61–69. https://doi.org/10.18093/0869-0189-2013-0-5-61-69
Yao, Y., Zhou, J., Diao, X., and Wang, S., Ther. Adv. Respir. Dis., 2019, vol. 13, 1753466619866096. https://doi.org/10.1177/1753466619866096
Yang, J., J. Int. Med. Res., 2020, vol. 48, no. 6, 300060520932104. https://doi.org/10.1177/0300060520932104
Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P.J., and Adcock, I.M., J. Exp. Med., 2006, vol. 203, no. 1, pp. 7–13. https://doi.org/10.1084/jem.20050466
Tan, C., Xuan, L., Cao, S., Yu, G., Hou, Q., and Wang, H., PLoS One, 2016, vol. 11, no. 1, e0147380. https://doi.org/10.1371/journal.pone.0147380
ACKNOWLEDGMENTS
The authors are grateful to the pulmonologists of the Minsk Clinical Consultative and Diagnostic Center E.I. Talabayeva and A.V. Plastinina for their assistance in this study.
Funding
The study was supported by the Belarusian State Scientific Program “Fundamental and Applied Sciences for Medicine” (task no. 2.56).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
The study was approved by the Biomedical Ethics Committee of Belarusian State Medical University (Protocol no. 8, January 21, 2019). All patients were informed about the goals, objectives, research methodology and gave written voluntary consent to participate in it.
CONFLICT OF INTEREST
The authors declare that they have no conflict of inte-rest.
Additional information
Translated by A. Medvedev
Rights and permissions
About this article
Cite this article
Kadushkin, A.G., Tahanovich, A.D., Movchan, L.V. et al. The Effect of Glucocorticoids in Combination with Azithromycin or Theophylline on Cytokine Production by NK and NKT-Like Blood Cells of Patients with Chronic Obstructive Pulmonary Disease. Biochem. Moscow Suppl. Ser. B 15, 337–344 (2021). https://doi.org/10.1134/S1990750821040053
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750821040053